Takeda Pharmaceutical Company Limited Stock
Stocks
4502
JP3463000004
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Japan Exchange
04:30:00 21/08/26 pm AEST
|
5-day change | 1st Jan Change | ||
| 5,764.00 JPY | -1.05% |
|
+2.73% | +19.21% |
| 21/08 | Pharma sector doubles down on AI amid hopes of slashing costs, timelines | RE |
| 19/08 | Asian Equities Traded in the US as American Depositary Receipts Track Lower in Tuesday Trading | MT |
| Market Cap | 9,204B 57.95B 49.64B 46.41B 42.56B 79.95B 5,539B 80.97B 543B 213B 2,783B 217B 213B | P/E 2027 * |
46.9x | P/E 2028 * | 29.8x |
|---|---|---|---|---|---|
| Enterprise Value | 13,106B 82.51B 70.68B 66.08B 60.6B 114B 7,887B 115B 774B 303B 3,962B 310B 303B | EV / Sales 2027 * |
2.8x | EV / Sales 2028 * | 2.71x |
| Free-Float |
99.26% | Yield 2027 * |
3.54% | Yield 2028 * | 3.61% |
Last Transcript: Takeda Pharmaceutical Company Limited
| 1 day | -1.05% | ||
| 1 week | +2.73% | ||
| Current month | +4.55% | ||
| 1 month | +3.82% | ||
| 3 months | +12.82% | ||
| 6 months | -0.45% | ||
| Current year | +19.21% |
| 1 week | 5,504 |  | 5,840 |
| 1 month | 5,225 | | 5,903 |
| Current year | 4,710 | | 6,033 |
| 1 year | 4,102 | | 6,033 |
| 3 years | 3,852 | | 6,033 |
| 5 years | 2,993 | | 6,033 |
| 10 years | 2,894.5 | | 6,693 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 01/01/2025 | |
Mikuno Furuta
DFI | Director of Finance/CFO | 48 | 01/04/2024 |
Gabriele Ricci
CTO | Chief Tech/Sci/R&D Officer | 47 | 01/02/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Andrew Plump
BRD | Director/Board Member | 60 | 01/06/2015 |
Steven Gillis
BRD | Director/Board Member | 73 | 01/01/2019 |
Mikuno Furuta
BRD | Director/Board Member | 48 | 01/06/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 18/8/26 | Sell | Head of Human Resources | -12,980 | 0.0008% | ||
| 11/8/26 | Sell | Pres., Global Supply & Quality | -20,363 | 0.0013% | ||
| 10/8/26 | Sell | Pres., Global Supply & Quality | -3,978 | 0.0002% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.05% | +2.73% | +25.60% | +30.91% | 57.89B | |
| +0.88% | +6.38% | +76.40% | +126.75% | 1,119B | |
| +1.07% | +3.80% | +50.73% | +62.78% | 651B | |
| +1.20% | +6.21% | +25.81% | +78.74% | 468B | |
| +1.02% | +5.77% | +43.63% | +48.43% | 374B | |
| +0.85% | +4.07% | +24.97% | +40.58% | 302B | |
| +1.26% | +6.81% | +2.27% | +14.41% | 259B | |
| +1.88% | +5.81% | +49.57% | +70.53% | 238B | |
| +1.59% | +2.09% | -17.33% | -52.62% | 208B | |
| +1.87% | +5.61% | +27.32% | +91.38% | 181B | |
| Average | +1.06% | +4.75% | +30.90% | +51.19% | 385.78B | |
| Weighted average by Cap. | +1.10% | +5.05% | +43.98% | +72.02% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 4,686B 29.5B 25.27B 23.63B 21.67B 40.71B 2,820B 41.22B 277B 108B 1,417B 111B 108B | 4,766B 30B 25.7B 24.03B 22.04B 41.4B 2,868B 41.92B 281B 110B 1,441B 113B 110B |
| Net income | 191B 1.2B 1.03B 964M 884M 1.66B 115B 1.68B 11.29B 4.42B 57.79B 4.51B 4.42B | 316B 1.99B 1.7B 1.59B 1.46B 2.74B 190B 2.78B 18.65B 7.31B 95.5B 7.46B 7.3B |
| Net Debt | 3,902B 24.57B 21.04B 19.67B 18.04B 33.9B 2,348B 34.33B 230B 90.34B 1,180B 92.16B 90.15B | 3,701B 23.3B 19.96B 18.66B 17.11B 32.15B 2,227B 32.56B 219B 85.68B 1,119B 87.41B 85.51B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 21/08/26 | JPY 5,764.00 | -1.05% | 3,177,000 |
| 20/08/26 | JPY 5,825.00 | +0.97% | 5,268,300 |
| 19/08/26 | JPY 5,769.00 | +1.18% | 6,779,900 |
| 18/08/26 | JPY 5,702.00 | +3.43% | 4,655,200 |
| 17/08/26 | JPY 5,513.00 | -1.75% | 2,529,900 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4502 Stock
Select your edition
All financial news and data tailored to specific country editions
